Show simple item record

dc.contributor.authorCunningham, Yvonne
dc.contributor.authorWood, Karen
dc.contributor.authorStewart, Carrie
dc.contributor.authorNakham, Athagran
dc.contributor.authorNewlands, Rumana
dc.contributor.authorGallacher, Katie I.
dc.contributor.authorQuinn, Terence J
dc.contributor.authorEllis, Graham
dc.contributor.authorLowrie, Richard
dc.contributor.authorMyint, Phyo Kyaw
dc.contributor.authorBond, Christine
dc.contributor.authorMair, Frances S.
dc.date.accessioned2022-01-06T15:39:01Z
dc.date.available2022-01-06T15:39:01Z
dc.date.issued2021-11-12
dc.identifier.citationCunningham , Y , Wood , K , Stewart , C , Nakham , A , Newlands , R , Gallacher , K I , Quinn , T J , Ellis , G , Lowrie , R , Myint , P K , Bond , C & Mair , F S 2021 , ' Understanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden : a qualitative study ' , Frontiers in Pharmacology , vol. 12 , 608208 . https://doi.org/10.3389/fphar.2021.608208en
dc.identifier.issn1663-9812
dc.identifier.otherPURE: 189790354
dc.identifier.otherPURE UUID: 80a535ac-572a-4f58-9a6c-6f3127bc906e
dc.identifier.otherPubMed: 34867311
dc.identifier.otherPubMedCentral: PMC8633300
dc.identifier.otherScopus: 85120429261
dc.identifier.urihttps://hdl.handle.net/2164/17796
dc.descriptionFunding statement This research was supported by the Chief Scientist Office under their Catalytic Research Grants Scheme, CSO reference number: CGA/18/47. Acknowledgments We gratefully acknowledge the support from the Alliance, the Glasgow Stroke Group and NKS in recruiting focus group participants and conducting the focus groups and Scottish Primary Care Research Network for recruiting patients from primary care. Special thanks to Irene Oldfather from Alliance and Naseem Suleman from NKS for their help in setting up interviews and focus groups. We gratefully acknowledge the research participants who provided their views and insights.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofFrontiers in Pharmacologyen
dc.rights© 2021 Cunningham, Wood, Stewart, Nakham, Newlands, Gallacher, Quinn, Ellis, Lowrie, Myint, Bond and Mair. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. https://creativecommons.org/licenses/by/4.0/en
dc.subjectanticholinergicsen
dc.subjectDeprescribingen
dc.subjectPolypharmacyen
dc.subjectinterviewsen
dc.subjectFocus Groupsen
dc.subjectQualitative Researchen
dc.subjectR Medicineen
dc.subjectChief Scientist Office (CSO)en
dc.subjectCGA/18/47en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleUnderstanding stakeholder views regarding the design of an intervention trial to reduce anticholinergic burden : a qualitative studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3389/fphar.2021.608208
dc.identifier.vol12en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record